LHCVX Mutual Fund

NAV$23.78

Fund Essentials - as of Jan 31, 2026

Net Assets
-
Expense Ratio
0.68%
Dividend Yield (Current)
0.35%
Holdings
61
Inception Date
Jul 31, 2019
Fund Family
Lord Abbett Family of Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+4.77%
1 Year+27.76%
3 Year+9.53%
5 Year+6.02%

Asset Allocation

Stocks: 95.05%
Cash: 0.76%
Other: 4.19%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co9.24%
GILDGilead Sciences Inc4.32%
-Fixed Inc Clearing Corp.Repo4.13%
AZN:LNAstraZeneca PLC3.96%
0QW0:ASargenx SE3.86%
Top 10 Concentration: 40.14%Report Date: Jan 31, 2026
Download all 61 holdings for LHCVX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.35%
Frequency
Annually
Latest Distribution
$1.47
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

LHCVX Mutual Fund Overview

LHCVX Mutual Fund (Lord Abbett Health Care Fund Class R6) is managed by Lord Abbett Family of Funds. LHCVX expense ratio is 0.68%, holding 61 positions across sectors including Health Care, Unknown, Other. Inception date: 2019-07-31.

LHCVX performance shows a YTD return of 4.77%. The 1-year return is 27.76% and the 5-year return is 6.02%. LHCVX dividend yield stands at 0.35%, paid annually.

LHCVX top holdings include Eli Lilly & Co (9.2%), Gilead Sciences Inc (4.3%), Fixed Inc Clearing Corp.Repo (4.1%), AstraZeneca PLC (4.0%), argenx SE (3.9%). View all LHCVX holdings, sector breakdown, or dividend history.

LHCVX can be compared against other funds using the overlap calculator or side-by-side comparison tool. LHCVX alternatives are available via the screener, along with tax-loss harvesting opportunities.